Brain Volume and Cardiac Function in Heart Failure
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- Johns Hopkins University
- Study ID
- NCT06623344
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Magnetic Resonance Imaging with or without Contrast — OTHERCompletion of Magnetic Resonance Imaging of the brain, heart, lungs, and liver with and without contrast.
Study Details
Patients with heart failure (HF) exhibit greater structural brain alterations and higher dementia risks than the general population. Neural atrophy in nearly every region of medical limbic circuit has been observed in HF patients. Reduction of cerebral blood flow has been suggested as the pathophysiological pathway linking HF and structural brain changes. Indeed, lower cardiac index levels were related to lower cerebral blood flow in older adults without stroke, dementia, or heart failure. A few prior studies have examined the subcortical structural differences in patients with HF compared to controls. Brain volume loss (including putamen and hippocampal volumes) have been reported in patients with low ejection fraction. Significant gray matter loss was found in specific brain regions of HF patients and included structures that serve demonstrated roles in cognitive functions. In the investigator's previous study (Comprehensive Imaging Exam of Convalesced COVID-19 Patients - COVID-19 RELATED SUBMISSION-IRB00252436), involving 100 participants (volunteers with normal heart function (ejection fraction; 50%)), the investigators observed significant correlations between thalamic volumes and ventricular stroke volumes in volunteers. Building on these findings, the investigators intend to expand the research to include individuals with heart failure (HF), employing the same MRI protocol. The study will involve obtaining a set of T1-weighted brain images to measure the volumes of seven subcortical structures. The investigators goal is to explore the relationship between subcortical volumes and cardiac parameters. Additionally, the investigators will examine whether patients with HF experience a more rapid reduction in subcortical volumes compared to those with normal cardiac function (EF;50%).
Key Dates
- Start date
- Nov 10, 2024
- Status verified
- Apr 2026
- Primary completion
- Oct 1, 2026
- Completion
- Oct 1, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Other: HospitalizedParticipants who were hospitalized due to heart failure (HF) illness.
- Other: Non-HospitalizedParticipants who had heart failure (HF) but did not require hospitalization secondary to the illness.
Primary Outcome Measure
Subcortical Volumes in Heart Failure [ Time Frame: From enrollment up to 30 days post treatment ]
Central Contacts
- Joao Lima, MD410-614-1284
- Jason Ortman
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Johns Hopkins Center for Advanced Imaging and Research Science, Johns Hopkins Science + Technology Park at 1812 Ashland Avenue, Baltimore, MD | Baltimore | Maryland | 21287 | Jason Ortman Joao AC Lima, MD (PRINCIPAL_INVESTIGATOR) |
| Johns Hopkins Hospital | Baltimore | Maryland | 21287 |
Find similar trials in Baltimore, MD
Related Studies
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting · Medtronic · Birmingham, Alabama
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and InflammationPHASE3 · Recruiting · Novo Nordisk A/S · Alexander City, Alabama